Skip to main content
DNA Labs India

BRCA1 and BRCA2 Genetic Testing in India: Hereditary Cancer Risk, Screening, and Prevention

Genomic & Hereditary Oncology | DNA Labs India

Genomic & Hereditary Oncology •

BRCA1 and BRCA2 Genetic Testing in India: Hereditary Cancer Risk, Screening, and Prevention

Learn about BRCA1 and BRCA2 genetic testing in India. Understand hereditary cancer risk, who should get tested, and how DNA Labs India provides accurate NGS-based screening.

BRCA1 and BRCA2 Genetic Testing in India: Hereditary Cancer Risk, Screening, and Prevention
BRCA1 and BRCA2 Genetic Testing in India: Hereditary Cancer Risk, Screening, and Prevention
Medical GeneticistGenomic & Hereditary Oncology
Written by: Nargis SultanaMedically Reviewed by: Dr Sulochana Hemchandra Holla, MBBS, MD (Medical Genetics)Last Updated: September 10, 2026

BRCA1 and BRCA2 Genetic Testing in India: Hereditary Cancer Risk, Screening, and Prevention

At a Glance

  • Sample Required: Blood or Saliva
  • Fasting Rules: Not required
  • Turnaround Time: 10-14 business days
  • Base Cost: [Insert Current 2026 Price]

Understanding Hereditary Breast and Ovarian Cancer

Breast cancer is the most common cancer among Indian women, with an estimated 2.4 million new cases projected by 2025. While most cases are sporadic, approximately 5-10% are hereditary, driven by mutations in high-penetrance genes such as BRCA1 and BRCA2. These genes normally act as tumor suppressors, repairing DNA damage and preventing uncontrolled cell growth. When mutated, they significantly increase the lifetime risk of breast, ovarian, and other cancers.

Genetic testing for BRCA1 and BRCA2 is a powerful tool for identifying individuals at elevated risk, enabling proactive screening and preventive strategies. DNA Labs India offers comprehensive NGS-based testing to provide accurate and actionable results.

BRCA1 and BRCA2: Key Differences

Both genes are involved in DNA repair, but they confer different cancer risks and are associated with distinct clinical features. The following table summarizes the key differences:

FeatureBRCA1BRCA2
Lifetime Breast Cancer RiskUp to 72%Up to 69%
Lifetime Ovarian Cancer RiskUp to 44%Up to 17%
Associated CancersBreast, Ovarian, Pancreatic, ProstateBreast, Ovarian, Pancreatic, Prostate, Melanoma
Triple-Negative Breast CancerMore commonLess common

Who Should Consider BRCA Genetic Testing?

Genetic testing is not recommended for everyone. It is most valuable for individuals with a personal or family history suggestive of hereditary cancer. The following criteria are based on clinical guidelines:

  • Diagnosed with breast cancer at age 50 or younger.
  • Two or more primary breast cancers (bilateral or ipsilateral).
  • Triple-negative breast cancer diagnosed at age 60 or younger.
  • Ovarian cancer at any age.
  • Male breast cancer.
  • Ashkenazi Jewish ancestry with a family history of breast or ovarian cancer.
  • Known BRCA mutation in a first-degree relative.

If you meet any of these criteria, genetic counseling is recommended before testing to understand the implications and limitations.

The Testing Process at DNA Labs India

DNA Labs India uses Next-Generation Sequencing (NGS) to analyze the full coding regions and splice sites of BRCA1 and BRCA2. This advanced technology ensures high accuracy and detection of all clinically relevant variants.

Sample Collection

A simple blood or saliva sample is collected at any of our collection centers. No fasting is required.

Turnaround Time

Results are typically available within 10-14 business days from sample receipt.

Interpretation of Results

Results are classified into three categories:

  1. Positive: A pathogenic mutation was found, indicating increased cancer risk.
  2. Negative: No pathogenic mutation detected; however, this does not eliminate hereditary risk from other genes.
  3. Variant of Uncertain Significance (VUS): A genetic change with unknown clinical impact. Further family studies may be needed.

Risk Management and Prevention Strategies

For individuals with a pathogenic BRCA mutation, enhanced surveillance and preventive measures can significantly reduce cancer risk. Options include:

  • Enhanced Screening: Annual breast MRI and mammography starting at age 25-30.
  • Chemoprevention: Medications such as tamoxifen or raloxifene for breast cancer risk reduction.
  • Prophylactic Surgery: Risk-reducing mastectomy or salpingo-oophorectomy, which can reduce risk by over 90%.
  • Targeted Therapies: For those already diagnosed, PARP inhibitors (e.g., olaparib) are effective in BRCA-mutated cancers.

These decisions should be made in consultation with a multidisciplinary team, including genetic counselors, oncologists, and surgeons.

Why Choose DNA Labs India for BRCA Testing?

  • ISO 9001 Certified Lab: We adhere to stringent quality standards.
  • Advanced NGS Technology: Comprehensive coverage of BRCA1 and BRCA2.
  • Expert Genetic Counseling: Our team includes certified genetic counselors to guide you.
  • Affordable Pricing: Transparent costs with no hidden charges.

Frequently Asked Questions

Is genetic testing covered by insurance?

Coverage varies by insurer. We recommend checking with your provider. DNA Labs India offers competitive self-pay rates.

Can I get tested without a doctor's referral?

While a referral is not mandatory, we strongly recommend genetic counseling before testing to ensure appropriate interpretation.

What if my result is a VUS?

Our genetic counselors will explain the implications and may suggest additional testing for family members to clarify the variant's significance.

Take Control of Your Health

Knowing your BRCA status empowers you to make informed decisions about your health. Early detection and preventive measures can save lives. If you have a family history of breast or ovarian cancer, talk to your doctor about genetic testing.

DNA Labs India is committed to providing accurate, reliable, and affordable genetic testing. Contact us today to schedule a consultation.

Your health is your wealth. Get tested and stay ahead.

Written by: Dr. [Author Name], MBBS, MD

Medically Reviewed by: Dr. [Reviewer Name], Medical Geneticist

Last Updated: [Current Date]

💡 Key Takeaways

  • •This article was written by Nargis Sultana.
  • •Last updated on September 10, 2026. Clinical information is reviewed periodically.
  • •Always consult with a qualified healthcare provider before making medical decisions based on the information presented here.

Need Personalized Clinical Guidance?

The information in this article is intended for educational purposes and reflects current scientific understanding. To understand how these insights apply to your specific health profile or family history, speak with a certified genetic counselor at DNA Labs India.

Medical Disclaimer: The clinical insights provided here are intended for educational purposes and do not replace professional medical advice from a primary physician. DNA Labs India is an ISO 9001:2015 certified diagnostic laboratory. Always consult with a qualified healthcare provider regarding any medical concerns, diagnoses, or treatment decisions.

Related Articles in Genomic & Hereditary Oncology

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.